ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984

Operative Laparoscopy Safe For Endometrial Cancer

April 30, 2004